Laxatives for the management of constipation in palliative care patients

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Miles, Clare L ^a   Fellowes, D ^b   Goodman, M L ^b   Wilkinson, W S ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DANTRON; LACTULOSE; LAXATIVE; LIQUID PARAFFIN; MAGNESIUM HYDROXIDE; MISRAKASNEHAM; MORPHINE; POLOXAMER; SENNA EXTRACT; UNCLASSIFIED DRUG;

BURNING SENSATION; CLINICAL TRIAL; COCHRANE LIBRARY; COLIC; CONSTIPATION; DEFECATION; DIARRHEA; DRUG EFFICACY; EMBASE; FECES; FECES INCONTINENCE; HOSPICE CARE; HUMAN; IRRITABLE COLON; MEDLINE; NAUSEA; PAIN; PALLIATIVE THERAPY; RANDOMIZATION; REVIEW; TERMINAL CARE; VOMITING;

EID: 42749106122     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003448.pub2     Document Type: Review

References (60)

1. Agra Y, Sacristan A, Gonzalez M, Ferrari M, Portugues A, Calvo MJ. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. Journal of Pain and Symptom Management 1998;15(1):1-7.
2. Ramesh P, Suresh Kumar K, Rajagopal M, Balachandran P, Warrier P. Managing morphine-induced constipation: a controlled comparison of the ayurvedic formulation and senna. Journal of Pain and Symptom Management 1998;16(4):240-4.
3. Sykes N. A clinical comparison of laxatives in a hospice. Palliative Medicine 1991;5:307-14.
4. Sykes N. A clinical comparison of lactulose and senna with magnesium hydroxide and liquid paraffin emulsion in a palliative care population. unpublished data 1991.
5. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-8.
6. Bennett M, Cresswell H. Factors inuencing constipation in advanced cancer patients: a prospective study of opioid, dose dantron and physical functioning. Palliative Medicine 2003;17:418-22.
7. Crowther A. Management of constipation in terminally ill patients. The Journal of International Medical Research 1978;6(4):348-50.
8. Daeninck PJ, Bruera E. Reduction in constipation and laxative requirements following. Journal of Pain and Symptom Management 1999;18:4.
9. Foss J. A Review of the Potential Role of Methylnaltrexone in Opiod Bowel Dysfunction. The American Journal of Surgery 2001;182(supp):19S- 26S.
10. Haazen L, Noorduin H, Megens A, Meert T. The constipation-inducing potential of morphine and transdermal fentanyl. European Journal of Pain 1999;3(Suppl, A):9-15.
11. Koninger JS, Butters M, Redecke JD, Z'graggen K. Transverse coloplasty pouch after total mesorectal excision: Functional assessment of evacuation. Diseases of the Colon & Rectum 2004;47(10):1586-93.
12. Maywin L, Wittbrodt E. Low Dose Oral Naloxone Reverses Opioid-Induced Constipation and Analgesia. Journal of Pain and Symptom Management 2002;23(1):48-53.
13. Muir JG, Yeow EG, Keogh J, Pizzey C, Bird AR, Sharpe K, et al. Combining wheat bran with resistent starch has more beneficial effects on fecal indexes than does wheat bran alone. American Journal of Clinical Nutrition 2004;79:1020-8.
14. Addison R, Smith M. Digital rectal examination and manual removal of faeces. Royal College of Nursing 2000, revised 2006;publication code 000 934:1-12.
15. Saunders JR, Williams NS, Eccersley AJP. The combination of electrically stimulated gracilis neonatal sphincter and continent colonic conduit: A step forward for total anorectal reconstruction?. Diseases of the Colon & Rectum 2004;47(3):354-63.
16. Schoorl J, Zylicz Z. Laxative policy for terminal patients ineffective. Nederlands Tijdscrift voor Geneeskunde 1997;141:823-6.
17. Spiller GA, Story JA, Furumoto EJ, Chezem JC, Spiller M. Effect of tartaric acid and dietary fibre from sun-dried raisins on colonic function and on bile acid and volatile fatty acid excretion in healthy adults. British Journal of Nutrition 2003;90:803-7.
18. Sykes NP. An investigation of the ability of oral naloxalones to correct opioid related constipation in patients with advanced cancer. Palliative Medicine 1996;10:135-44.
19. Sykes N. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliative Medicine 1998;12:375- 82.
20. Walsh D, Doona M, Molnar M, Lipnickey V. Symptom control in advanced cancer: important drugs and routes of administration. Seminars in Oncology 2000;27(1):69-83.
21. Wenk R, Bertolino M, Ochoa J, Cullen C, Bertucelli N, Bruera E. Laxative effects of fresh baker's yeast (letter). Journal of Pain and Symptom Management 2000;19(3):163-4.
22. Wirz S, Klaschik E. Laxative use and efficacy in palliative care of patients with cancer pain and morphine therapy. A retrospective study with special regard to polyethylene glycol. Schmerz 2003;17(4):233-9.
23. Cimprach B. Symptom management: constipation. Cancer Nursing 1985;8(supp 1):39-43.
24. Culbert P, Gillett H, Ferguson A. Highly effective new oral therapy for faecal impaction. British Journal of General Practice 1998;48:1599-6000.
25. Daenick P, Bruera E. Reduction in constipation and laxative requirements following opioid rotation to methadone: a report of four cases. Journal of Pain and Symptom Management 1999;18:303-9.
26. Dorland I, Newman WA. Dorland's Illustrated Medical Dictionary. Book. 27th Edition. Philadelphia: WB Saunders Co, 1988.
27. Dunlop GM. A study of the relative frequency and importance of gastrointestinal symptoms and weakness in patients with far advanced cancer. Palliative Medicine 1989;4:37-43.
28. Goodman ML, Low J, Wilkinson S. Constipation management in palliative care: a survey of practices in the UK. Journal of Pain and Symptom Management 2005;29(3):24-38.
29. Hall ET. The silent language. Greenwich, CT: Fawcet Publishers, 1959.
30. Hillier. Autonomic dysreexia. Stoke Mandeville internal document 1996.
31. Hurdon V, Viola R, Schorder C. How useful is docusate in patients at risk for constipation? A systematic review of the evidence in the chronically ill. Journal of Pain and Symptom Management 2000;19:130-6.
32. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
33. Klaschik E, Nauck F, Ostgathe C. Constipation - modern laxative therapy. Supportive Care in Cancer 2003;11:679-85.
34. Levy M. Constipation in cancer patients. The Cancer Bulletin 1991.
35. Lovell T. Restlessness in end-stage disease. Palliative Care Today 1994;3:12-3.
36. Maestri-Banks A, Burns D. Assessing constipation. Nursing Times 1996;92(21):28-30.
37. McMillan SC, Williams FA. Validity and reliability of the constipation assessment scale. Cancer Nursing 1989;12(3):183-8.
38. McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. The Journal of Pain 2003;4(5):231-56.
39. McNicol ED, Boyce D, Carr DB. Mu-opioid antagonists for opioid-induced bowel dysfunction. Protocol intended for Issue 1, 2007 of The Cochrane Library.
40. Miaskowski C. Putting the cancer pain guideline into practice. Capsules and Comments in Oncology Nursing 1995;3:9-15.
41. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommedations for improving the quality of reports of parallel group randomized trials. BMC Medical Research Methodology 2001;357:1191-4.
42. Norton C. The causes and nursing management of constipation. British Journal of Nursing 1996;3:1252-8.
43. Petticrew M, Watt I, Sheldon T. Systematic review of the effectiveness of laxatives in the elderly. Health Technology Assessment 1997; Vol. 1, issue 13.
44. Portenoy RK. Constipation in the cancer patient: causes and management. Medical Clinics of North America 1987;71:303-11.
45. Poulton B, Thomas S. The nursing management of constipation. Primary Health Care 1999;9:17-22.
46. Quigley C. Opioid switiching to improve pain relief and drug tolerability. In: The Cochrane Database of Systematic Reviews, 3, 2004. Chichester: John Wiley & Sons.
47. Radbruch L, Sabatowski R, Loick G, et al. Constipation and the use of laxatives: a comparison between transdermal fentanyl andd oral morphine. Palliative Medicine 2000;14:111-9.
48. Rinck GC, Van den Bos GAM, Kleijnen J, de Haes HJCJM, Schade E, Veenhof CHN. Methodological issues in effectiveness research on palliative cancer care: a systematic review. Journal of Clinical Oncology 1997;15:1697- 707.
49. Robinson C, Fritch M, Hullet L, et al. Development of a protocol to prevent opioid-induced constipation in patients with cancer - a research utilisation project. Clinical Journal of Oncology Nursing 2000;4:79-84.
50. Ross H. Constipation: cause and control in an acute hospital setting. British Journal of Nursing 1998;7(15):907-13.
51. Ross D, Alexander C. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea. American Family Physician 2001;64(6):1019-26.
52. Sykes NP. Current approaches to the management of constipation. Cancer Surveys 1994;21:137-46.
53. Sykes NP. A volunteer model for the comparison of laxative opioid-related constipation. Journal of Pain and Symptom Management 1996;11:363-9.
54. Sykes NP. Constipation management in palliative care. Geriatric Medicine 1997;27:55-7.
55. Tamayo AC, Diaz-Zuluaga PA. Management of opioid-induced bowel dysfunction in cancer patients. Supportive Care in Cancer 2004;12:613-8.
56. Tramonte SM, Mulrow CD, Amato MG, O'Keefe ME, Ramirez G. The treatment of chronic constipation in adults: a systematic review. Journal of General Internal Medicine 1997;12:15-24.
57. World Health Organisation. Cancer pain relief: with a guide to opioid availability. WHO Office of Publication, Geneva 1996;2nd Edition: Geneva.
58. Winney J. Constipation. Primary Health Care 1998;8:31-6.
59. Withell B. A protocol for treating acute constipation in the community setting. British Journal of Community Nursing 2000;5:110-7.
60. Wright PS, Thomas SL. Constipation and diarrhoea: the neglected symptoms. Seminars in Oncology Nursing 1995;11:289-97.